Background— The prevalence of the endothelium-impaired function disorders, such as
hypertension and diabetes mellitus, and the severity of their complications are considerably …

Background— Alterations in endothelial function may contribute to increased susceptibility
of black Americans to cardiovascular disease. The ability to pharmacologically reverse …

Background— Nebivolol and carvedilol are third-generation β-adrenoreceptor antagonists,
which unlike classic β-blockers, have additional endothelium-dependent vasodilating …

This study investigated the process of nitric oxide (NO) release from platelets after stimulation
with different angiotensin II type 1 (AT 1 )-receptor antagonists and its effect on platelet …

The impact of statin therapy on plasma asymmetric dimethylarginine (ADMA) levels has not
been conclusively studied. Therefore the aim of the meta-analysis was to assess the effect of …

Cardiovascular diseases (CVDs) are the leading cause of death worldwide. The initial stage
of CVDs is characterized by endothelial dysfunction, defined as the limited bioavailability of …

Background— Although statins preserve endothelial function by reducing serum cholesterol
levels, it has been suggested they may also stimulate nitric oxide (NO) synthase in …

Nitric oxide (NO) is one of the most important molecules released by endothelial cells, and
its antiatherogenic properties support cardiovascular homeostasis. Diminished NO …

The proteasome has key roles in neuronal proteostasis, including the removal of misfolded
and oxidized proteins, presynaptic protein turnover, and synaptic efficacy and plasticity. …

There is growing evidence that endothelial dysfunction, which is often defined as the
decreased endothelial-derived nitric oxide (NO) bioavailability, is a crucial factor leading to …